|By Business Wire||
|March 11, 2013 08:04 AM EDT||
NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has been recognized by the American Academy of Sleep Medicine (AASM) as the first Approved Out of Center Sleep Test Provider (AOCSTP). The approval validates compliance with the Academy’s recently updated quality standards for out of center testing, and provides a fast track pathway for sleep centers performing in-home testing to maintain or obtain AASM accreditation by partnering with an AASM-approved out of center sleep test provider.
“The American Academy of Sleep Medicine congratulates NovaSom for being the first company to earn the Approved OCST Provider designation,” said AASM President Sam Fleishman, MD. “This designation reflects a commitment to excellence in the provision of out of center sleep testing and confirms that the services provided by NovaSom meet AASM accreditation standards. Sleep centers that are interested in outsourcing some OCST services can have confidence in knowing that their contract arrangement with an Approved OCST Provider will maintain the high quality of their diagnostic patient care.”
NovaSom’s sleep center partnership model, AccuSom Deliver™, allows the sleep physician to remain at the center of OSA management, in complete clinical control of their patients, while leveraging AccuSom Deliver’s turnkey service that meets or exceeds all AASM standards -- well ahead of the August 1, 2013 date when the new standards will be applied to all out of center sleep testing (OCST) in AASM-accredited sleep centers. NovaSom’s program enables physicians to focus on patient care, raw test data and interpretation by relieving them of the burden of device and sensor purchasing, calibration, repair and warehousing; software purchasing; infection control; device serial number tracking; additional personnel; 24/7 support and patient waiting lists.
“We are proud that the Academy has recognized NovaSom’s commitment to accurate, high quality, cost-effective in-home testing for OSA, and our consistency in providing an excellence experience for patients and sleep specialists alike. AASM’s leadership in the quality standards and adoption of out of center sleep testing by sleep specialists will improve quality and access to care for millions of Americans,” said Michael Coppola, MD, NovaSom’s Chief Medical Officer and longstanding member of the AASM. “Health insurers, benefit managers, employers, physicians and patients have a new gold standard by which they can evaluate the quality of home testing.”
Leveraging more than ten years' experience with turnkey OCST, the AccuSom Deliver program allows sleep centers to enjoy the scale and operating efficiency of the NovaSom platform. Once a sleep specialist prescribes an OCST through NovaSom’s proprietary cloud-based portal, NovaSom provides the device to the patient at home. NovaSom's Clinical Team provides proactive, 24/7 clinical support to patients throughout the testing protocol, leveraging the wireless test data provided by its proprietary AccuSom device, the nation’s only FDA-cleared wireless home sleep test device.
For more information about NovaSom’s OCST technology and the AccuSom Deliver program, please visit www.NovaSom.com.
Obstructive Sleep Apnea (OSA) affects 40 million Americans, of which 18 million have moderate to severe disease. Of these, a startling 85% of sufferers are undiagnosed and therefore untreated, generating significant medical expense for patients and the healthcare system. Nearly half of all OSA patients also suffer from one or more serious health conditions such as diabetes, hypertension or heart failure that are either aggravated or caused by OSA. Treating OSA reduces medical expenses, improves patient quality of life and lowers associated health risks.
About NovaSom, Inc.
NovaSom, Inc. is the market leader in Obstructive Sleep Apnea (OSA) home testing, with the AccuSom® Home Sleep Test, the first and only FDA-cleared wireless HST. The NovaSom home sleep testing technology and MediTrack® portal have been shown to provide in-home, clinically equivalent diagnosis of OSA at a significantly reduced cost as compared to in-facility testing for uncomplicated, adult OSA. NovaSom's home sleep tests are currently covered for more than 150 million commercially insured U.S. lives.
NovaSom also offers comprehensive service programs that enable significant cost savings for OSA management. In an effort to combat the growing OSA epidemic, NovaSom partners with sleep centers, enabling sleep specialists to offer clinically appropriate patients an alternative, convenient testing option, expanding access to diagnosis and treatment.
NovaSom is also accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center & Telehealth Provider and is classified by CMS as an Independent Diagnostic Testing Facility. For more information, visit www.NovaSom.com.